These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37151072)
1. An Analytical Method for Determination of Total Iron in Pharmaceuticalgrade Intravenous Iron Colloidal Complexes by Redox-Potentiometry. Kamisetty MK; Medisetty R; Ramesh B; Pappureddy S; Kashanna J; Govinda V; Kishore R Pharm Nanotechnol; 2023; 11(5):486-492. PubMed ID: 37151072 [TBL] [Abstract][Full Text] [Related]
3. Ferrous iron content of intravenous iron formulations. Gupta A; Pratt RD; Crumbliss AL Biometals; 2016 Jun; 29(3):411-5. PubMed ID: 26956439 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379 [TBL] [Abstract][Full Text] [Related]
5. An analytical method for Fe(II) and Fe(III) determination in pharmaceutical grade iron sucrose complex and sodium ferric gluconate complex. Merli D; Profumo A; Dossi C J Pharm Anal; 2012 Dec; 2(6):450-453. PubMed ID: 29403781 [TBL] [Abstract][Full Text] [Related]
6. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Lyseng-Williamson KA; Keating GM Drugs; 2009; 69(6):739-56. PubMed ID: 19405553 [TBL] [Abstract][Full Text] [Related]
7. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Funk F; Flühmann B; Barton AE Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216261 [TBL] [Abstract][Full Text] [Related]
9. Complexation of iron(III) and iron(II) by citrate. Implications for iron speciation in blood plasma. Königsberger LC; Königsberger E; May PM; Hefter GT J Inorg Biochem; 2000 Feb; 78(3):175-84. PubMed ID: 10805173 [TBL] [Abstract][Full Text] [Related]
10. Determination of organically bound iodine by reductive mineralization with aluminium powder. Analytical methods of pharmacopoeias with DBH in respect to environmental and economical concern. Part 16. Hilp M Pharmazie; 2002 Jul; 57(7):471-3. PubMed ID: 12168528 [TBL] [Abstract][Full Text] [Related]
11. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy. Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529 [TBL] [Abstract][Full Text] [Related]
12. An Optimized Process for the Preparation of Aqueous Ferric Carboxymaltose: Synthesis and Structural Characterization. Tabasi O; Razlighi MR; Darbandi MA Pharm Nanotechnol; 2021; 9(2):157-163. PubMed ID: 33459254 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Neiser S; Koskenkorva TS; Schwarz K; Wilhelm M; Burckhardt S Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455240 [TBL] [Abstract][Full Text] [Related]
14. Transition metal complexes as mediator-titrants in protein redox potentiometry. Bernhardt PV; Chen KI; Sharpe PC J Biol Inorg Chem; 2006 Oct; 11(7):930-6. PubMed ID: 16868742 [TBL] [Abstract][Full Text] [Related]
15. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients. Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615 [TBL] [Abstract][Full Text] [Related]
16. Potentiometric determination of iodine in pharmaceutical preparations. Vandeputte M; Dryon L; De Hertogh L; Massart DL J Pharm Sci; 1979 Nov; 68(11):1416-8. PubMed ID: 512892 [TBL] [Abstract][Full Text] [Related]
17. Potentiometric assessment of iron release during ferritin reduction by exogenous agents. Vladimirova LS; Kochev VK Anal Biochem; 2010 Sep; 404(1):52-5. PubMed ID: 20434425 [TBL] [Abstract][Full Text] [Related]
18. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Friedrisch JR; Cançado RD Rev Bras Hematol Hemoter; 2015; 37(6):400-5. PubMed ID: 26670403 [TBL] [Abstract][Full Text] [Related]
19. Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations. Kudasheva DS; Lai J; Ulman A; Cowman MK J Inorg Biochem; 2004 Nov; 98(11):1757-69. PubMed ID: 15522403 [TBL] [Abstract][Full Text] [Related]